TPI1 Antikörper (N-Term)
Kurzübersicht für TPI1 Antikörper (N-Term) (ABIN630577)
Target
Alle TPI1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- TPI1 antibody was raised against the N terminal of TPI1
-
Aufreinigung
- Affinity purified
-
Immunogen
- TPI1 antibody was raised using the N terminal of TPI1 corresponding to a region with amino acids MAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYID
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
TPI1 Blocking Peptide, (ABIN5616740), is also available for use as a blocking control in assays to test for specificity of this TPI1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of TPI1 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- TPI1 (Triosephosphate Isomerase 1 (TPI1))
-
Andere Bezeichnung
- TPI1
-
Hintergrund
- TPI1 belongs to the triosephosphate isomerase family. Defects in TPI1 are the cause of triosephosphate isomerase deficiency (TPI deficiency) . TPI deficiency is an autosomal recessive disorder. It is the most severe clinical disorder of glycolysis. It is associated with neonatal jaundice, chronic hemolytic anemia, progressive neuromuscular dysfunction, cardiomyopathy and increased susceptibility to infection.
-
Molekulargewicht
- 27 kDa (MW of target protein)
-
Pathways
- Cell RedoxHomeostasis
Target
-